Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient

被引：2

作者：

Shimizu, Kazuhiro ^{[1
,3
]}

Tabata, Tsuyoshi ^{[2
]}

Iwakawa, Masahiro ^{[1
]}

Sato, Shuji ^{[1
]}

Kinoshita, Toshio ^{[1
,2
]}

机构：

[1] Toho Univ, Div Cardiovasc Med, Dept Internal Med, Sakura Med Ctr, Chiba, Japan

[2] Toho Univ, Sakura Med Ctr, Dept Gastroenterol, Chiba, Japan

[3] Toho Univ, Sakura Med Ctr, Dept Internal Med, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan

来源：

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL | 2023年 / 16卷

关键词：

hypertension; angiotensin receptor-neprilysin inhibitor; arterial stiffness; cardio ankle vascular index; CARDIOVASCULAR INTERACTION; CHAMBER QUANTIFICATION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; ECHOCARDIOGRAPHY; NEPRILYSIN; RECOMMENDATIONS; INHIBITOR; STIFFNESS; RECEPTOR;

D O I：

10.2147/IMCRJ.S422196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 72-year-old man presented to our clinic with hypertension. Arterial stiffness evaluated by cardio ankle vascular index (CAVI) was markedly increased at 13.5. We treated him using 80 mg/day of valsartan for three months. CAVI was decreased from 13.5 to 13.0. However, his BP fluctuations were still high. We changed the treatment to angiotensin receptor-neprilysin inhibitor (ARNI) with increasing doses up to 400 mg. Independent of the change in blood pressure at the time of measurement, CAVI improved with ARNI dose. Hypertension treatment with an awareness of the cardio-vascular interaction might be a possibility prevents future heart failure development effectively.

引用

页码：461 / 465

页数：5

共 13 条

[1] Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and applications
Hayashi, Kozaburo
Yamamoto, Tomoyuki
Takahara, Akira
Shirai, Kohji
[J]. JOURNAL OF HYPERTENSION, 2015, 33 (09) : 1742 - 1757
[2] Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
Kario, Kazuomi
Sun, Ningling
Chiang, Fu-Tien
Supasyndh, Ouppatham
Baek, Sang Hong
Inubushi-Molessa, Akiko
Zhang, Ying
Gotou, Hiromi
Lefkowitz, Martin
Zhang, Jack
[J]. HYPERTENSION, 2014, 63 (04) : 698 - 705
[3] Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
Lang, RM
Bierig, M
Devereux, RB
Flachskampf, FA
Foster, E
Pellikka, PA
Picard, MH
Roman, MJ
Seward, J
Shanewise, JS
Solomon, SD
Spencer, KT
Sutton, MS
Stewart, WJ
[J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2005, 18 (12) : 1440 - 1463
[4] Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Lang, Roberto M.
Badano, Luigi P.
Mor-Avi, Victor
Afilalo, Jonathan
Armstrong, Anderson
Ernande, Laura
Flachskampf, Frank A.
Foster, Elyse
Goldstein, Steven A.
Kuznetsova, Tatiana
Lancellotti, Patrizio
Muraru, Denisa
Picard, Michael H.
Rietzschel, Ernst R.
Rudski, Lawrence
Spencer, Kirk T.
Tsang, Wendy
Voigt, Jens-Uwe
[J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (03) : 233 - 271
[5] Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
McMurray, John J. V.
Packer, Milton
Desai, Akshay S.
Gong, Jianjian
Lefkowitz, Martin P.
Rizkala, Adel R.
Rouleau, Jean L.
Shi, Victor C.
Solomon, Scott D.
Swedberg, Karl
Zile, Michael R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 993 - 1004
[6] Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
Miguel Ruilope, Luis
Dukat, Andrej
Boehm, Michael
Lacourciere, Yves
Gong, Jianjian
Lefkowitz, Martin P.
[J]. LANCET, 2010, 375 (9722) : 1255 - 1266
[7] The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
Schmieder, Roland E.
Wagner, Frank
Mayr, Michael
Delles, Christian
Ott, Christian
Keicher, Christian
Hrabak-Paar, Maja
Heye, Tobias
Aichner, Solveig
Khder, Yasser
Yates, Denise
Albrecht, Diego
Langenickel, Thomas
Freyhardt, Patrick
Janka, Rolf
Bremerich, Jens
[J]. EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3308 - 3317
[8] A Case Demonstrating the Cardio-Vascular Interaction by a New Cardio-Ankle Vascular Index During the Treatment of Concentric Hypertrophy
Shimizu, Kazuhiro
Tabata, Tsuyoshi
Kiyokawa, Hajime
Morinaga, Yukihiro
Sato, Shuji
Mikamo, Hiroshi
Nakagami, Takahiro
Iiduka, Takuo
Shirai, Kohji
Noro, Mahito
[J]. CARDIOLOGY RESEARCH, 2019, 10 (01) : 54 - 58
[9] A novel blood pressure-independent arterial wall stiffness parameter; Cardio-ankle vascular index (CAVI)
Shirai, K
Utino, J
Otsuka, K
Takata, M
[J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (02) : 101 - 107
[10] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D.
McMurray, J. J. V.
Anand, I. S.
Ge, J.
Lam, C. S. P.
Maggioni, A. P.
Martinez, F.
Packer, M.
Pfeffer, M. A.
Pieske, B.
Redfield, M. M.
Rouleau, J. L.
van Veldhuisen, D. J.
Zannad, F.
Zile, M. R.
Desai, A. S.
Claggett, B.
Jhund, P. S.
Boytsov, S. A.
Comin-Colet, J.
Cleland, J.
Dungen, H. -D.
Goncalvesova, E.
Katova, T.
Kerr Saraiva, J. F.
Lelonek, M.
Merkely, B.
Senni, M.
Shah, S. J.
Zhou, J.
Rizkala, A. R.
Gong, J.
Shi, V. C.
Lefkowitz, M. P.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17) : 1609 - 1620

← 1 2 →